Literature DB >> 23551095

Role of SHIP1 in bone biology.

Sonia Iyer1, Bryan S Margulies, William G Kerr.   

Abstract

The bone marrow milieu comprising both hematopoietic and nonhematopoietic lineages has a unique structural organization. Bone undergoes continuous remodeling throughout life. This dynamic process involves a balance between bone-forming osteoblasts (OBs) derived from multipotent mesenchymal stem cells (MSCs) and bone-resorbing osteoclasts (OCs) derived from hematopoietic stem cells (HSCs). Src homology 2-domain-containing inositol 5'-phosphatase 1 (SHIP1) regulates cellular processes such as proliferation, differentiation, and survival via the PI3K/Akt signaling pathway initiated at the plasma membrane. SHIP1-deficient mice also exhibit profound osteoporosis that has been proposed to result from hyperresorptive activity by OCs. We have previously observed that SHIP1 is expressed in primary OBs, which display defective development in SHIP1-deficient mice. These findings led us to question whether SHIP1 plays a functional role in osteolineage development from MSC in vivo, which contributes to the osteoporotic phenotype in germline SHIP1 knockout mice. In this short review, we discuss our current understanding of inositol phospholipid signaling downstream of SHIP1 in bone biology.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551095      PMCID: PMC3670113          DOI: 10.1111/nyas.12091

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

1.  Cbfa1 as a regulator of osteoblast differentiation and function.

Authors:  G Karsenty; P Ducy; M Starbuck; M Priemel; J Shen; V Geoffroy; M Amling
Journal:  Bone       Date:  1999-07       Impact factor: 4.398

2.  Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells.

Authors:  Shingo Maeda; Makoto Hayashi; Setsuro Komiya; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

3.  Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.

Authors:  T Tsurukai; N Udagawa; K Matsuzaki; N Takahashi; T Suda
Journal:  J Bone Miner Metab       Date:  2000       Impact factor: 2.626

4.  USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma.

Authors:  Samuel A Williams; Heather L Maecker; Dorothy M French; Jinfeng Liu; Andrew Gregg; Leah B Silverstein; Tim C Cao; Richard A D Carano; Vishva M Dixit
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

Review 5.  Inhibitor and activator: dual functions for SHIP in immunity and cancer.

Authors:  William G Kerr
Journal:  Ann N Y Acad Sci       Date:  2010-12-13       Impact factor: 5.691

6.  TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation.

Authors:  T Alliston; L Choy; P Ducy; G Karsenty; R Derynck
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

7.  Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion.

Authors:  John M Perry; Xi C He; Ryohichi Sugimura; Justin C Grindley; Jeffrey S Haug; Sheng Ding; Linheng Li
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

8.  SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts.

Authors:  Sunao Takeshita; Noriyuki Namba; Jenny J Zhao; Yebin Jiang; Harry K Genant; Matthew J Silva; Michael D Brodt; Cheryl D Helgason; Janet Kalesnikoff; Michael J Rauh; R Keith Humphries; Gerald Krystal; Steven L Teitelbaum; F Patrick Ross
Journal:  Nat Med       Date:  2002-08-05       Impact factor: 53.440

9.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

10.  Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells.

Authors:  Ying Peng; Quan Kang; Qing Luo; Wei Jiang; Weike Si; Bernard A Liu; Hue H Luu; Jong Kyung Park; Xinmin Li; Jeffrey Luo; Anthony G Montag; Rex C Haydon; Tong-Chuan He
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

View more
  10 in total

1.  ALX1-transcribed LncRNA AC132217.4 promotes osteogenesis and bone healing via IGF-AKT signaling in mesenchymal stem cells.

Authors:  Cui Zhang; Shali Wu; Erman Chen; Luyang Yu; Jinfu Wang; Mengrui Wu
Journal:  Cell Mol Life Sci       Date:  2022-05-31       Impact factor: 9.261

Review 2.  Discovery and development of small molecule SHIP phosphatase modulators.

Authors:  William G Kerr; John D Chisholm; Dennis R Viernes; Lydia B Choi
Journal:  Med Res Rev       Date:  2013-12-02       Impact factor: 12.944

3.  TLR signaling that induces weak inflammatory response and SHIP1 enhances osteogenic functions.

Authors:  Manoj Muthukuru; Richard P Darveau
Journal:  Bone Res       Date:  2014-11-11       Impact factor: 13.567

4.  Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial.

Authors:  Sophie E Rowbotham; Jenna L Pinchbeck; Georgina Anderson; Bernie Bourke; Michael Bourke; T Christian Gasser; Rene Jaeggi; Jason S Jenkins; Corey S Moran; Susan K Morton; Christopher M Reid; Ramesh Velu; Lisan Yip; Joseph V Moxon; Jonathan Golledge
Journal:  Trials       Date:  2017-11-16       Impact factor: 2.279

5.  Genome-wide DNase hypersensitivity, and occupancy of RUNX2 and CTCF reveal a highly dynamic gene regulome during MC3T3 pre-osteoblast differentiation.

Authors:  Phillip W L Tai; Hai Wu; André J van Wijnen; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

6.  Quantitative Proteomics Revealed the Pharmacodynamic Network of Bugu Shengsui Decoction Promoting Osteoblast Proliferation.

Authors:  Xu Wei; Baoyu Qi; Ruyun Ma; Yili Zhang; Ning Liu; Shengjie Fang; Yanning Zhu; Yanming Xie; Jianye Dai; Liguo Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-25       Impact factor: 5.555

7.  SHIP1 Activator AQX-1125 Regulates Osteogenesis and Osteoclastogenesis Through PI3K/Akt and NF-κb Signaling.

Authors:  Xudong Xie; Liangcong Hu; Bobin Mi; Adriana C Panayi; Hang Xue; Yiqiang Hu; Guodong Liu; Lang Chen; Chenchen Yan; Kangkang Zha; Ze Lin; Wu Zhou; Fei Gao; Guohui Liu
Journal:  Front Cell Dev Biol       Date:  2022-04-04

Review 8.  Hypoxia-Inducible Factors Signaling in Osteogenesis and Skeletal Repair.

Authors:  Qiuyue Qin; Yiping Liu; Zhen Yang; Maierhaba Aimaijiang; Rui Ma; Yixin Yang; Yidi Zhang; Yanmin Zhou
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

Review 9.  Targeting SHIP1 and SHIP2 in Cancer.

Authors:  Chiara Pedicone; Shea T Meyer; John D Chisholm; William G Kerr
Journal:  Cancers (Basel)       Date:  2021-02-20       Impact factor: 6.639

Review 10.  Role of inositol poly-phosphatases and their targets in T cell biology.

Authors:  Neetu Srivastava; Raki Sudan; William Garrow Kerr
Journal:  Front Immunol       Date:  2013-09-23       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.